Thane, India

Alagumurugan Alagarswamy


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alagumurugan Alagarswamy: Innovator in Pharmaceutical Formulations

Introduction

Alagumurugan Alagarswamy is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for cancer treatment. With a total of 2 patents to his name, Alagarswamy is recognized for his innovative approaches to drug formulation.

Latest Patents

Alagarswamy's latest patents focus on stable pharmaceutical formulations of pemetrexed. The inventions relate to a long-term storage stable multi-dose ready-to-use or ready-to-dilute pharmaceutical liquid formulation. This formulation comprises pemetrexed or a pharmaceutically acceptable salt thereof, along with an antioxidant, a preservative, a buffering agent, and a pharmaceutically acceptable fluid. The invention also includes a process for preparing the formulation, a kit, and a method for treating patients with lung cancer by administering the pharmaceutical formulation to those in need.

Career Highlights

Alagarswamy is currently associated with Cipla Limited, a leading pharmaceutical company. His work at Cipla has allowed him to focus on innovative drug formulations that can improve patient outcomes. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Alagarswamy has collaborated with notable colleagues such as Sarabjit Singh and Madhusudhan Malladi. These collaborations have further enhanced his research capabilities and contributed to the success of his inventions.

Conclusion

Alagumurugan Alagarswamy is a distinguished inventor whose work in pharmaceutical formulations has the potential to make a significant impact on cancer treatment. His innovative spirit and dedication to improving healthcare are commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…